FBR Capital Maintains a 'Market Perform' on Emerson (EMR); Uninspiring Quarter As Price-Cost Issues Linger On
Tweet Send to a Friend
FBR Capital maintains a 'Market Perform' on Emerson (NYSE: EMR), PT $60.
FBR analyst says, "We have a positive bias ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "We have a positive bias ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
